These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21496377)

  • 1. Plasma procalcitonin: another arrow in our quiver?
    Luyt CE; Chastre J
    Respir Care; 2011 Apr; 56(4):530-2. PubMed ID: 21496377
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic utility of plasma procalcitonin for nosocomial pneumonia in the intensive care unit setting.
    Dallas J; Brown SM; Hock K; Scott MG; Skrupky LP; Boyle WA; Kollef MH
    Respir Care; 2011 Apr; 56(4):412-9. PubMed ID: 21255510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventilator - associated pneumonia and the role of procalcitonin.
    Mahdi AD
    Acta Med Indones; 2005; 37(3):170-2. PubMed ID: 16135880
    [No Abstract]   [Full Text] [Related]  

  • 4. Procalcitonin in intensive care units: the PRORATA trial.
    Mokart D; Leone M
    Lancet; 2010 May; 375(9726):1605; author reply 1606-7. PubMed ID: 20452515
    [No Abstract]   [Full Text] [Related]  

  • 5. Procalcitonin in intensive care units: the PRORATA trial.
    Tarnow-Mordi W; Gebski V
    Lancet; 2010 May; 375(9726):1605; author reply 1606-7. PubMed ID: 20452513
    [No Abstract]   [Full Text] [Related]  

  • 6. Procalcitonin in intensive care units: the PRORATA trial.
    Gibot S
    Lancet; 2010 May; 375(9726):1605-6; author reply 1606-7. PubMed ID: 20452514
    [No Abstract]   [Full Text] [Related]  

  • 7. Procalcitonin monitoring in trauma intensive care patients: how helpful is it?
    Jensen JU; Lundgren J
    Crit Care Med; 2009 Jun; 37(6):2093-4. PubMed ID: 19448450
    [No Abstract]   [Full Text] [Related]  

  • 8. C-reactive protein, procalcitonin, clinical pulmonary infection score, and pneumonia severity scores in nursing home acquired pneumonia.
    Porfyridis I; Georgiadis G; Vogazianos P; Mitis G; Georgiou A
    Respir Care; 2014 Apr; 59(4):574-81. PubMed ID: 24106319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current status of biomarkers for the diagnosis of nosocomial pneumonias.
    Salluh JIF; Souza-Dantas VC; Póvoa P
    Curr Opin Crit Care; 2017 Oct; 23(5):391-397. PubMed ID: 28759466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin and antibiotic therapy: can we improve antimicrobial stewardship in the intensive care setting?
    Riedel S
    Crit Care Med; 2012 Aug; 40(8):2499-500. PubMed ID: 22809920
    [No Abstract]   [Full Text] [Related]  

  • 11. Will procalcitonin reduce antibiotic use in intensive care?
    Kollef MH
    Lancet; 2010 Feb; 375(9713):435-6. PubMed ID: 20097416
    [No Abstract]   [Full Text] [Related]  

  • 12. Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia.
    Ugajin M; Yamaki K; Hirasawa N; Yagi T
    Respir Care; 2014 Apr; 59(4):564-73. PubMed ID: 24170911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients.
    Layios N; Lambermont B; Canivet JL; Morimont P; Preiser JC; Garweg C; Ledoux D; Frippiat F; Piret S; Giot JB; Wiesen P; Meuris C; Massion P; Leonard P; Nys M; Lancellotti P; Chapelle JP; Damas P
    Crit Care Med; 2012 Aug; 40(8):2304-9. PubMed ID: 22809906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum procalcitonin levels in patients with mild community-acquired pneumonia.
    Beović B; Kreft S; Osredkar J; Kese D; Bonac-Tuma B
    Clin Microbiol Infect; 2005 Dec; 11(12):1050-1. PubMed ID: 16307566
    [No Abstract]   [Full Text] [Related]  

  • 15. New diagnostic and prognostic markers of ventilator-associated pneumonia.
    Chastre J; Luyt CE; Trouillet JL; Combes A
    Curr Opin Crit Care; 2006 Oct; 12(5):446-51. PubMed ID: 16943724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A procalcitonin-guided algorithm for pneumonia may reduce antibiotic use and treatment duration].
    Berg P; Lindhardt BØ
    Ugeskr Laeger; 2012 Aug; 174(35):1986-9. PubMed ID: 22929575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in community-acquired pneumonia.
    Krüger S; Welte T
    Expert Rev Respir Med; 2012 Apr; 6(2):203-14. PubMed ID: 22455492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of the mean platelet volume, neutrophil to lymphocyte ratio, and C-reactive protein compared to the procalcitonin level in pneumonia patients.
    Lee JH; Yoon SY; Kim HS; Lim CS
    Platelets; 2015; 26(3):278-80. PubMed ID: 24528090
    [No Abstract]   [Full Text] [Related]  

  • 19. [Community-acquired pneumonia and procalcitonin, an opportunity to improve?].
    Tudela P; Mòdol JM
    Med Clin (Barc); 2014 Apr; 142(7):303-5. PubMed ID: 24183120
    [No Abstract]   [Full Text] [Related]  

  • 20. Procalcitonin in intensive care units: the PRORATA trial.
    Landman GW; Kleefstra N
    Lancet; 2010 May; 375(9726):1606; author reply 1606-7. PubMed ID: 20452516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.